CClinicalTrials.gg
Status unknownNCT05640921Updated Dec 7, 2022

Group-integrated Cognitive Behavioural Therapy (Gi-CBT) to Aid Communities' Reintegration of Former Terrorists in Nigeria: A Randomised Control Trial

An interventional study of Gi-CBT and Media Orientation in Depression, Trauma and Anxiety, sponsored by Teesside University. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-07.

Sponsored by Teesside University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The project aims to make significant contributions that change the conversation in communities and policy circles through promoting knowledge of nonviolent peace strategies using the Group integrated Cognitive Behavioural Therapy (Gi-CBT) to help heal trauma, improve peace, and encourage positive rehabilitation and reintegration of former Boko Haram terrorists' members and their families.

Read the detailed description

The main question it aims to answer are:

  • What is the feasibility in terms of recruitment, retention, adherence to the intervention and communities/victims' satisfaction with Gi-CBT to promote healing and improve the successful reintegration of of former Boko Haram terrorists' members and their families.into society?

Participants will be randomly allocated into two groups. The first group, the intervention group, will receive the Group integrated Cognitive Behavioural Therapy (Gi-CBT). The second group will receive government intervention involving media messages from the National Orientation Agency devoid of GiCBT.

Researchers will compare Gi-CBT group with the media orientation group to see if there are differences between a change in attitude towards ex-offenders' reintegration at base line, end of intervention and three months follow up.

02

Conditions studied

  • Depression
  • Trauma
  • Anxiety
  • Fear

Browse trials for

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 24 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Teesside University is the lead sponsor of 54 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. community members who had previous experience of trauma as a result of Boko Haram atrocities, score 5 and above for the culturally-adapted Trauma Screening Questionnaire (Brewinn et al., 2002)
  2. are aged 18+ years and above
  3. are residents of the designated areas including Bornu (Maiduguri), and its environs.

Exclusion criteria

Exclusion Criteria:

  • those not meeting the study inclusion criteria will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Group-integrated Cognitive Behavioural Therapy (Gi-CBT)

    The Gi-CBT sessions will cover relevant aspects of tackling trauma, and the CBT component will involve addressing negative thoughts, building more positive ones and building resilience through post-traumatic situations and adversities.

    Behavioral: Gi-CBT

  • Active comparator
    Media Intervention

    The second group will receive Media Orientation (MO). The MO sessions will embed media content to create awareness of the government's approaches to reintegration.

    Other: Media Orientation

Interventions

  • BehavioralGi-CBT

    Gi-CBT designed to cover relevant aspects of tackling trauma, and the CBT component will involve addressing negative thoughts, building more positive ones and building resilience.

  • OtherMedia Orientation

    The MO sessions will embed media content to create awareness of the government's approaches to reintegration.

06

What researchers measure

Primary outcomes

  1. Service Satisfaction Scale

    Change in service satisfaction is being assessed

    Time frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

  2. PHQ-9

    Change in Depressive Symptoms

    Time frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

  3. The Attitude Towards Repentant Terrorist and their Reintegration scale

    Change in attitude towards reintegration

    Time frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

  4. Trauma Screening Questionnaire

    Change in traumatic experience is being assessed

    Time frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05640921
Lead sponsor
Teesside University
Collaborators
Coal City University
Responsible party
Tarela Ike (Dr, Teesside University) — Principal investigator
First posted
Dec 7, 2022
Start date
Dec 20, 2022 (estimated)
Primary completion
Nov 30, 2023 (estimated)
Completion
Nov 30, 2023 (estimated)
Last update
Dec 7, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion